LPCN News and Press, Lipocine Inc. From 03/04/21

Lipocine Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic Fibrosis PR Newswire SALT LAKE CITY , March 4, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinic...

Lipocine Announces Presentations on TLANDO™ at ENDO 2021 Conference PR Newswire SALT LAKE CITY , March 3, 2021 - /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, tod...

Lipocine to Present at Two Upcoming Investor Conferences PR Newswire SALT LAKE CITY , Feb. 26, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Com...

Lipocine Closes Underwritten Public Offering Of Common Stock PR Newswire SALT LAKE CITY , Jan. 28, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the c...

So far, in 2021, it seems as though this is the year of penny stocks . Many companies have seen their share prices shoot up in the triple or even quadruple digits in the past twelve months. While this is not only due to the pandemic, it does have a huge influence. If anything, Covid has...

Gainers: Oxbridge Re (OXBR) +62%.Koss (KOSS) +60%.AIkido Pharma (AIKI) +51%.Vertex Energy (VTNR) +56%.Phunware (PHUN) +45%.Edesa Biotech (EDSA) +33%.CarParts.com (PRTS) +32%.Workhorse Group (WKHS) +30%.Orbital Energy (OEG) +27%.Vir Biotechnology (VIR) +27%.Losers: Express ...

Gainers: Vir Biotechnology VIR +39%, AIkido Pharma (AIKI) +37%, Edesa Biotech EDSA +34%, Motus GI Holdings (MOTS) +29%, Regional Health Properties (RHE) +24%.Losers: Lipocine (LPCN) -18%, Capricor Therapeutics (CAPR) -17%, Iterum Therapeutics ...

Lipocine Prices $25 Million Underwritten Public Offering Of Common Stock PR Newswire SALT LAKE CITY , Jan. 26, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today ann...

Repro Med Systems (KRMD) -18% on preliminary FY20 results and CEO transition.Sanchez Midstream Partners (SNMP) -17%.Express (EXPR) -16% as Wedbush sees company 'hemorrhaging cash'.Lipocine (LPCN) -14% on launch of public offering.Midatech Pharma (MTP) -10%&#...

Lipocine (LPCN) slumped 11.8% in after hours trade after planning to offer shares for sale in an underwritten public offering; underwriters granted 30-day option to purchase up to an additional 15% of the shares.Offer size, terms have not yet been disclosed.Proceeds to be used for g...